lunes, 22 de enero de 2018

Mylotarg Makes A Comeback For Leukemia - Ivanhoe Broadcast News, Inc.

Mylotarg Makes A Comeback For Leukemia - Ivanhoe Broadcast News, Inc.

Marketing


Mylotarg was heralded as the first targeted therapy for leukemia in the U.S. in 2000. But it was withdrawn when further testing showed increased mortality rates! After extensive testing, it is back on the market with a new dosing and specific target




More than seven million Americans suffer from essential tremor, a disease that causes their hands to shake uncontrollably. Now, a new non-invasive procedure is helping stop the tremors almost instantly




Breast cancer kills more than 40,000 women every year, and one in eight women in the U.S. will be diagnosed with it in her lifetime. One scientist is earning accolades for her research that is stopping cancer cells in their tracks




Virtual reality and 3D modeling are now making complex surgeries easier for not only the patients, but med students, doctors, radiologists, and even surgeons! See how they are being used to educate everyone involved




There has been a major spike in cases of thyroid cancer within the past few decades. Researchers are now studying one possible cause for this, and unfortunately it lurks where you probably feel the safest!










Quote of the week:

You may call God love, you may call God goodness, but the best name for God is compassion.” 

— Meister Eckhart


Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!
 




Website Information: webdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario